Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Bolivikang Pharmaceutical Research Institute is a high-tech enterprise based in Beijing, China, specializing in pharmaceutical research and development services. The company primarily operates as a Contract Research Organization (CRO), providing comprehensive services including drug synthesis, formulation development, and quality control analysis. They focus on the development of generic drugs and improved new drugs, particularly in the fields of cardiovascular health, metabolic diseases, and anti-infectives. Bolivikang is known for its technical expertise in complex formulations and has successfully supported numerous domestic pharmaceutical companies in obtaining regulatory approvals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Bolivikang Pharmaceutical Research Institute.